✦ LIBER ✦

A Phase I Study of Paclitaxel/Doxorubicin/Thalidomide in Patients with Androgen-Independent Prostate Cancer

✍ Scribed by Robert J. Amato; Harmeet Sarao

Book ID: 115075913
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 491 KB
Volume: 4
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2006.n.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of GM-CSF + thalidomide i

Phase II trial of GM-CSF + thalidomide in patients with androgen-independent metastatic prostate cancer

✍ Robert Dreicer; Eric A. Klein; Paul Elson; David Peereboom; Tatiana Byzova; Edwa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

An open-label phase II study of low-dose

An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer

✍ Drake, M J; Robson, W; Mehta, P; Schofield, I; Neal, D E; Leung, H Y 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

868 A tolerance and efficacy study of th

868 A tolerance and efficacy study of thalidomide, paclitaxel, estramustine combination for patients with chemotherapy refractory androgen independent prostate carcinoma

✍ D. Daliani; P. Dieringer; P. Matthew; L. Pagliaro; K. Davies; N. Tannir; I. Chen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Phase II study evaluating oral triamcino

Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer

✍ Sandy Srinivas; Aruna V. Krishnan; Natalia Colocci; David Feldman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

A randomized phase II trial of docetaxel

A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer

✍ William D Figg; Phil Arlen; James Gulley; Patricia Fernandez; Marianne Noone; Ka 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 578 KB

Multicenter Phase II study of estramusti

Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma

✍ David J. Vaughn; Archie W. Brown Jr.; W. Graydon Harker; Sang Huh; Lance Miller; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Abstract ## BACKGROUND The current study determined the efficacy and toxicity of weekly paclitaxel in combination with estramustine phosphate (EMP) in patients with androgen‐independent prostate carcinoma (AIPC). ## METHODS Patients with progressive AIPC received 90 mg/m^2^ paclitaxel by 1‐ho